Wells Fargo & Company Night Hawk Biosciences, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Night Hawk Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 194 shares of NHWK stock, worth $31. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194
Previous 191
1.57%
Holding current value
$31
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NHWK
# of Institutions
32Shares Held
2.21MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY397KShares$63,4710.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny391KShares$62,6180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$58,1950.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL283KShares$45,2860.32% of portfolio
-
Geode Capital Management, LLC Boston, MA211KShares$33,8370.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...